United Kingdom Hip Reconstruction Market, Major Players, Trends And Future Scope: Ken Research

1

• United Kingdom Hip Recontrcution Market, Major
  Players, Trends And Future Scope Ken Research

2

• According to the study, UNITED KINGDOM HIP
  RECONSTRUCTION MARKET OUTLOOK TO 2025, few
  dominant players in the United Kingdom Hip
  Reconstruction Market are Zimmer Biomet Holdings
  Inc, DePuy Synthes Inc, Stryker Corp, Corin Group
  PLC, Smith Nephew Plc.
• The increasing number of the elderly people
  especially in the developed countries has raised
  the demand for healthcare systems all around the
  globe. Hip reconstruction is prominently present
  in the people aged above 60 years of age. Most of
  the people who undergo this surgery claim this to
  be a cost effective surgery considering the end
  stage of the condition. The changing level and
  nature of demand from the elderly to young people
  has resulted in a supply deficiency. Initiative
  by government and NGOs to maintain a national
  waiting list in the United Kingdom has reduced
  the potential threat of a long waiting list. With
  limited funding, it has become a prerequisite for
  companies to keep a close track of the demand in
  order to decide on the target market both in
  terms of age groups and geography.

3

• Most of the pharmaceutical industry around the
  world is dominated by only a few players and is
  highly concentrated. Similar is the case with
  United Kingdoms hip reconstruction industry
  which is dominated by international players with
  deep pockets. Uncertainty is a key factor that is
  prevalent in the United Kingdom hip
  reconstruction market. Research and development
  teams are constantly coming up with new
  technologies which make the entire market
  dynamic. Also, since newer medicines are being
  developed that claim to cure this condition, it
  puts this market in a dangerous position. United
  Kingdom indentifies small number of companies
  supplying wide varieties of brands and products
  in the market which is dominated by Zimmer and
  Stryker Osteonics. The Hip Prosthesis in the
  United Kingdom forms only a small portion of the
  global industry.

4

• JRI orthopedics is an implant manufacturer in
  United Kingdom which is wholly owned by British
  Furlong Research Charitable Foundation. This
  company is present only in UK market,
  manufacturing implants only. There are two
  variants of hip reconstruction material available
  in the market and these are cemented and cement
  less which has high degree of substitutability.
  National Health Service in UK is considered to be
  the monopolist buyer however, recent trend has
  showcased that hospitals are also procuring
  implants directly from the manufacturer. Due to
  the supply deficiency that is present in the
  market, many patients are being denied access to
  the treatment which significantly reduces their
  experience of undergoing the procedure.

5

• The entire UK hip reconstruction market is
  expected to have a steady but slow growth in the
  coming years due to certain key factors. This
  includes high concentration in the market coupled
  with research and development in oral medication
  to treat this condition entirely and also due to
  the supply deficiency that is present in the
  market. This has also created problems for the
  new entrants in the market. If companies wish to
  enter this industry in the United Kingdom, they
  need to come up with new technology that is not
  only is cost effective but also which has the
  potential to improve patients post treatment
  experience.

6

• To know more, click on the link below
• https//www.kenresearch.com/healthcare/medical-dev
  ices/uk-hip-reconstruction/151108-91.html
• Related Reports
• https//www.kenresearch.com/healthcare/medical-dev
  ices/france-hip-reconstruction-market/151115-91.ht
  ml
• https//www.kenresearch.com/healthcare/medical-dev
  ices/us-hip-reconstruction/151101-91.html
• Contact UsKen ResearchAnkur Gupta, Head
  Marketing Communicationssales_at_kenresearch.com
• 91-9015378249

7
(No Transcript)